These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9048434)

  • 61. Pharmacology of antiepileptic drugs in clinical practice.
    Guimarães J; Ribeiro JA
    Neurologist; 2010 Nov; 16(6):353-7. PubMed ID: 21150382
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.
    Knezevic NN; Yekkirala A; Yaksh TL
    Anesth Analg; 2017 Nov; 125(5):1714-1732. PubMed ID: 29049116
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emerging molecular approaches to pain therapy.
    Williams M; Kowaluk EA; Arneric SP
    J Med Chem; 1999 May; 42(9):1481-500. PubMed ID: 10229619
    [No Abstract]   [Full Text] [Related]  

  • 64. Structure-Activity Studies Reveal the Molecular Basis for GABA
    Sadeghi M; Carstens BB; Callaghan BP; Daniel JT; Tae HS; O'Donnell T; Castro J; Brierley SM; Adams DJ; Craik DJ; Clark RJ
    ACS Chem Biol; 2018 Jun; 13(6):1577-1587. PubMed ID: 29746088
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Guidelines on migraine: part 5. Recommendations for specific prophylactic drugs.
    Morey SS
    Am Fam Physician; 2000 Dec; 62(11):2535-9. PubMed ID: 11130237
    [No Abstract]   [Full Text] [Related]  

  • 66. Nonsurgical management of urolithiasis: an overview of expulsive therapy.
    Healy KA; Ogan K
    J Endourol; 2005 Sep; 19(7):759-67. PubMed ID: 16190824
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Calcium influx through N-methyl-D-aspartate receptors triggers GABA release at interneuron-Purkinje cell synapse in rat cerebellum.
    Glitsch MD
    Neuroscience; 2008 Jan; 151(2):403-9. PubMed ID: 18055124
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The efficacy of N-methyl-D-aspartate receptor antagonists on improving the postoperative pain intensity and satisfaction after remifentanil-based anesthesia in adults: a meta-analysis.
    Wu L; Huang X; Sun L
    J Clin Anesth; 2015 Jun; 27(4):311-24. PubMed ID: 25824051
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [NMDA-receptor antagonist in pain therapy].
    Weber C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Aug; 33(8):475-83. PubMed ID: 9746842
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Pharmacotherapy and analysis of the course of pregnancy and perinatal outcomes in women with hypertensive disease].
    Striuk RI; Bukhonkina IuM; Sokova EA; Nemirovskiĭ VB; Kosmacheva AV
    Kardiologiia; 2009; 49(12):29-32. PubMed ID: 20038278
    [No Abstract]   [Full Text] [Related]  

  • 71. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.
    Miljanich GP
    Curr Med Chem; 2004 Dec; 11(23):3029-40. PubMed ID: 15578997
    [TBL] [Abstract][Full Text] [Related]  

  • 72. NMDA antagonists and neuropathic pain--multiple drug targets and multiple uses.
    Chizh BA; Headley PM
    Curr Pharm Des; 2005; 11(23):2977-94. PubMed ID: 16178757
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Emerging trends in the pharmacotherapy of chronic pain.
    Nitu AN; Wallihan R; Skljarevski V; Ramadan NM
    Expert Opin Investig Drugs; 2003 Apr; 12(4):545-59. PubMed ID: 12665411
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Reflex sympathetic dystrophy.
    Schott GD
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):291-5. PubMed ID: 11511699
    [No Abstract]   [Full Text] [Related]  

  • 75. Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interferes with alpha-2-mediated analgesia.
    Gil DW; Cheevers CV; Kedzie KM; Manlapaz CA; Rao S; Tang E; Donello JE
    Anesthesiology; 2009 Feb; 110(2):401-7. PubMed ID: 19194166
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevention of cocaine-induced convulsions and lethality in mice: effectiveness of targeting different sites on the NMDA receptor complex.
    Brackett RL; Pouw B; Blyden JF; Nour M; Matsumoto RR
    Neuropharmacology; 2000 Jan; 39(3):407-18. PubMed ID: 10698007
    [TBL] [Abstract][Full Text] [Related]  

  • 77. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders.
    Krystal JH; D'Souza DC; Petrakis IL; Belger A; Berman RM; Charney DS; Abi-Saab W; Madonick S
    Harv Rev Psychiatry; 1999; 7(3):125-43. PubMed ID: 10483932
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 1992 Bonica Lecture. Advances in chronic pain management since gate control.
    Abram SE
    Reg Anesth; 1993; 18(2):66-81. PubMed ID: 8098221
    [TBL] [Abstract][Full Text] [Related]  

  • 79. GABAA receptor stimulation enhances NMDA-induced Ca2+ influx in mouse cerebral cortical neurons in primary culture.
    Ohkuma S; Chen DZ; Katsura M; Chen SH; Kuriyama K
    Brain Res Mol Brain Res; 1994 Nov; 27(1):145-51. PubMed ID: 7877444
    [TBL] [Abstract][Full Text] [Related]  

  • 80. NMDA receptors as targets for drug action in neuropathic pain.
    Parsons CG
    Eur J Pharmacol; 2001 Oct; 429(1-3):71-8. PubMed ID: 11698028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.